AR054198A1 - Derivados de benzotiazol-2-ona como inhibidores de lipasas y fosflipasas - Google Patents
Derivados de benzotiazol-2-ona como inhibidores de lipasas y fosflipasasInfo
- Publication number
- AR054198A1 AR054198A1 ARP060102371A ARP060102371A AR054198A1 AR 054198 A1 AR054198 A1 AR 054198A1 AR P060102371 A ARP060102371 A AR P060102371A AR P060102371 A ARP060102371 A AR P060102371A AR 054198 A1 AR054198 A1 AR 054198A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkylene
- alkyl
- nr9r10
- alkylamino
- heteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Ophthalmology & Optometry (AREA)
Abstract
Composiciones farmacéuticas que los contienen, método d preparacion y usos en la prevencion de trastornos de metabolismo de ácidos grasos y trastornos de utilizacion de glucosa. Reivindicacion 1: Un compuesto de formula (1) en la que los significados son R1 es alquilo C5-16, alquileno C1-4-arilo C6-10, alquileno C1-4-heteroarilo C5-12, alquileno C1-4-cicloalquilo C4-12, biciclo C8-14, donde el arilo, heteroarilo, cicloalquilo o biciclo pueden estar sustituidos una o más veces con halogeno, alquilo C1-6, alquiloxi C1-3, alquilmercapto C1-6, amino, alquilamino C1-6, di-alquilamino C2-12, mono-alquilaminocarbonilo C1-6, di-alquilaminocarbonilo C2-8, alcoxicarbonilo C1-6, alquilcarbonilo C1-6, ciano, trifluorometilo, trifluorometoxi, alquilsulfonilo C1-6 o aminosulfonilo; R2 es H, alquilo C1-6; o R1 y R2 forman junto con el átomo de N que los tiene un sistema de anillos monocíclico, saturado o parcialmente insaturado, de 4 a 7 miembros o un sistema de anillos bicíclico, saturado o parcialmente insaturado, de 8 a 14 miembros, donde los miembros individuales de los sistemas de anillos pueden reemplazarse con uno a tres átomos o grupos atomicos de la serie -CHR8-, -CR8R8a-, -(C=R8)-, -NR9-, -C(=O)-, -O-, -S- , -SO-, -SO2-, con la condicion de que dos unidades de la serie -O-, -S-, -SO-, -SO2- no pueden ser adyacentes; R3 es H; R4, R5 son iguales o diferentes y son hidrogeno, halogeno, alquilo C1-6, alquiloxi C1-3-alquileno C1-3, hidroxi, alquilmercapto C1-6, amino, alquilamino C1-6, di-alquilamino C2-12, -alquilcarbonilo C1-6, CO-OR7, trifluorometilo, alquilsulfonilo C1-6, alquilsulfinilo C1-6, aminosulfonilo, pentafluorosulfanilo, arilo C6-10, heteroarilo C5-12, CO-NR9R10, O-CO-NR9R10, O-CO- alquileno C1-8-CO-O-alquilo C1-6, O-CO-alquileno C1-6-CO-OH, O-CO-alquileno C1-6-CO-NR9R10 o alquiloxi C1-6 sin sustituir o mono- o poli-F-sustituido; R6 es hidrogeno, alquiloxi C1-3-alquileno C1-3, hidroxi, alquilmercapto C1-6, amino, alquilamino C1-6, di-alquilamino C2-12, pentafluorosulfanilo, arilo C6-10, heteroarilo C5-12, CO-NR9R10, O-CO-NR9R10, O-CO-alquileno C1-6-CO-O-alquilo C1-6, O-CO-alquileno C1-6-CO-OH, O-CO-alquileno C1-6-CO-NR9R10 o alquiloxi C1-6 sin sustituir o mono- o poli-F- sustituido; con la condicion de que no más de uno de los sustituyentes R3, R4, R5 sea halogeno, trifluorometilo o alquilo C1-6; R7 es hidrogeno, alquilo C1-6, bencilo; R8, R8a son iguales o diferentes y son alquilo C1-6, halogeno, trifluorometilo, CO-OR7, ciclopropilo, ciclopropileno; R9, R10 son iguales o diferentes y son hidrogeno, alquilo C1-6, -arilo C6-10, -heteroarilo C5-12, cicloalquilo C3-12, alquileno C1-4-arilo C6-10, alquileno C1-C4-heteroarilo C5-12, alquileno C1-4-cicloalquilo C3- 12, biciclo C8-14; las formas tautoméricas de los compuestos y sales fisiologicamente toleradas de los mismos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005026809A DE102005026809A1 (de) | 2005-06-09 | 2005-06-09 | Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen |
Publications (1)
Publication Number | Publication Date |
---|---|
AR054198A1 true AR054198A1 (es) | 2007-06-06 |
Family
ID=36699315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060102371A AR054198A1 (es) | 2005-06-09 | 2006-06-07 | Derivados de benzotiazol-2-ona como inhibidores de lipasas y fosflipasas |
Country Status (21)
Country | Link |
---|---|
US (1) | US8008331B2 (es) |
EP (1) | EP1896435B1 (es) |
JP (1) | JP2008542411A (es) |
KR (1) | KR20080014020A (es) |
CN (1) | CN101189218A (es) |
AR (1) | AR054198A1 (es) |
AT (1) | ATE495163T1 (es) |
AU (1) | AU2006257023A1 (es) |
BR (1) | BRPI0611918A2 (es) |
CA (1) | CA2609560A1 (es) |
DE (2) | DE102005026809A1 (es) |
IL (1) | IL187729A0 (es) |
MA (1) | MA29482B1 (es) |
MX (1) | MX2007015269A (es) |
MY (1) | MY146803A (es) |
NO (1) | NO20080034L (es) |
NZ (1) | NZ564061A (es) |
RU (1) | RU2007145476A (es) |
TW (1) | TW200716581A (es) |
UY (1) | UY29594A1 (es) |
WO (1) | WO2006131232A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005026808A1 (de) * | 2005-06-09 | 2006-12-14 | Sanofi-Aventis Deutschland Gmbh | Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US8470841B2 (en) | 2008-07-09 | 2013-06-25 | Sanofi | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
JP5605844B2 (ja) | 2008-10-17 | 2014-10-15 | 塩野義製薬株式会社 | 血管内皮リパーゼ阻害活性を有する酢酸アミド誘導体 |
CA2784710A1 (en) | 2009-12-15 | 2011-06-23 | Shionogi & Co., Ltd. | Oxadiazole derivative having endothelial lipase inhibitory activity |
CN101845027B (zh) * | 2010-05-28 | 2012-11-21 | 浙江工业大学 | 一种n-取代苯基-苯并噻唑酮-3-甲酰胺衍生物 |
US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2101150A1 (de) * | 1971-01-12 | 1972-08-03 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Substituierte Benzthiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Akarizide und Insektizide |
JPS60105671A (ja) * | 1983-11-14 | 1985-06-11 | Idemitsu Kosan Co Ltd | ベンゾチアゾロン誘導体、その製造方法およびそれを有効成分とする農園芸用殺菌剤 |
JPS61155376A (ja) * | 1984-12-28 | 1986-07-15 | Idemitsu Kosan Co Ltd | ベンゾチアゾロン誘導体,その製造方法およびそれを有効成分とする農園芸用殺菌剤 |
DE3835576A1 (de) * | 1988-03-25 | 1989-10-12 | Bayer Ag | 3,7-disubstituierte benzthiazolone |
JP2005518376A (ja) * | 2001-12-14 | 2005-06-23 | ノボ ノルディスク アクティーゼルスカブ | 化合物およびホルモン感受性リパーゼの活性を低下させるためのその使用 |
DE10247680B4 (de) * | 2002-10-12 | 2005-09-01 | Aventis Pharma Deutschland Gmbh | Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase |
-
2005
- 2005-06-09 DE DE102005026809A patent/DE102005026809A1/de not_active Withdrawn
-
2006
- 2006-05-27 JP JP2008515096A patent/JP2008542411A/ja not_active Abandoned
- 2006-05-27 RU RU2007145476/04A patent/RU2007145476A/ru not_active Application Discontinuation
- 2006-05-27 AU AU2006257023A patent/AU2006257023A1/en not_active Abandoned
- 2006-05-27 BR BRPI0611918-2A patent/BRPI0611918A2/pt not_active IP Right Cessation
- 2006-05-27 CN CNA2006800199269A patent/CN101189218A/zh active Pending
- 2006-05-27 MX MX2007015269A patent/MX2007015269A/es active IP Right Grant
- 2006-05-27 KR KR1020077028744A patent/KR20080014020A/ko not_active Application Discontinuation
- 2006-05-27 NZ NZ564061A patent/NZ564061A/en not_active IP Right Cessation
- 2006-05-27 AT AT06753938T patent/ATE495163T1/de active
- 2006-05-27 DE DE502006008717T patent/DE502006008717D1/de active Active
- 2006-05-27 EP EP06753938A patent/EP1896435B1/de active Active
- 2006-05-27 CA CA002609560A patent/CA2609560A1/en not_active Abandoned
- 2006-05-27 WO PCT/EP2006/005096 patent/WO2006131232A1/de not_active Application Discontinuation
- 2006-06-07 AR ARP060102371A patent/AR054198A1/es not_active Application Discontinuation
- 2006-06-07 TW TW095120138A patent/TW200716581A/zh unknown
- 2006-06-07 MY MYPI20062624A patent/MY146803A/en unknown
- 2006-06-09 UY UY29594A patent/UY29594A1/es not_active Application Discontinuation
-
2007
- 2007-11-22 MA MA30416A patent/MA29482B1/fr unknown
- 2007-11-28 IL IL187729A patent/IL187729A0/en unknown
- 2007-12-05 US US11/950,948 patent/US8008331B2/en not_active Expired - Fee Related
-
2008
- 2008-01-03 NO NO20080034A patent/NO20080034L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2006257023A1 (en) | 2006-12-14 |
CA2609560A1 (en) | 2006-12-14 |
MY146803A (en) | 2012-09-28 |
BRPI0611918A2 (pt) | 2010-10-05 |
ATE495163T1 (de) | 2011-01-15 |
CN101189218A (zh) | 2008-05-28 |
TW200716581A (en) | 2007-05-01 |
MX2007015269A (es) | 2008-02-21 |
EP1896435B1 (de) | 2011-01-12 |
WO2006131232A1 (de) | 2006-12-14 |
IL187729A0 (en) | 2008-08-07 |
US20080161370A1 (en) | 2008-07-03 |
DE102005026809A1 (de) | 2006-12-14 |
UY29594A1 (es) | 2007-01-31 |
JP2008542411A (ja) | 2008-11-27 |
US8008331B2 (en) | 2011-08-30 |
EP1896435A1 (de) | 2008-03-12 |
NZ564061A (en) | 2010-07-30 |
RU2007145476A (ru) | 2009-06-20 |
DE502006008717D1 (de) | 2011-02-24 |
KR20080014020A (ko) | 2008-02-13 |
MA29482B1 (fr) | 2008-05-02 |
NO20080034L (no) | 2008-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR054198A1 (es) | Derivados de benzotiazol-2-ona como inhibidores de lipasas y fosflipasas | |
AR078786A1 (es) | Derivados de la cromenona | |
AR078152A1 (es) | Compuestos heterociclicos, utiles para el tratamiento de hcv y composiciones farmaceuticas que los comprenden | |
AR070469A1 (es) | Derivados de naftiridina y composiciones farmaceuticas como inhibidores de quinasa con actividad sobre c- kit y pdgfr | |
AR083199A1 (es) | Compuestos de n-heteroarilo con unidad de puente ciclico | |
AR049711A1 (es) | Compuestos heterociclicos condensados como inhibidores de la aldosterona sintasa; composiciones farmaceuticas que los contienen y su uso en la preparacion de un medicamento para el tratamiento o prevencion de enfermedades relacionadas con el hiperaldosterismo y por una liberacion excesiva de cortiso | |
AR032624A1 (es) | Derivados de fenilamina ciclica, uso de los mismos para la fabricacion de medicamentos y composicion farmaceutica | |
AR080785A1 (es) | Derivados de imidazo[1,2-a]pirimidina ,proceso para prepararlos e intermediarios de dicha sintesis, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de patologias del sistema nervioso central,tales como esquizofrenia y parkinson, entre otros. | |
AR058095A1 (es) | Derivados de triazolopiridina en calidad de inhibidores de lipasas y fosfolipasas. procesos de obtencion y composiciones farmaceuticas. | |
AR066583A1 (es) | Derivados de 3,3-espiroindolinona | |
AR084394A1 (es) | Combinaciones de principios activos con propiedades insecticidas y acaricidas | |
AR056686A1 (es) | Derivados de diacilindazol como inhibidores de lipasas y fosfolipasas | |
AR077434A1 (es) | Compuestos para la reduccion de produccion de beta - amiloide | |
AR053232A1 (es) | Derivados de piridina condensadas, composiciones farmaceuticas que los contienen y su empleo en la fabricacion de agentes terapeuticos antiinflamatorios y para el tratamiento de enfermedades relacionadas con el sistema inmunologico. | |
AR085960A1 (es) | 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2 | |
AR082826A2 (es) | Inhibidores heterociclicos de mek, composiciones farmaceuticas que los contienen, usos, y metodos de preparacion de los mismos | |
AR073598A1 (es) | Pirrolidinas 2-carboxamidas sustituidas, composiciones farmaceuticas que las contienen y uso de las mismas como agentes anticancer. | |
AR054560A1 (es) | Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
AR061374A1 (es) | Derivados de diamidas de acido antranilico con sus sustituyentes heteroaromaticos y heterociclicos | |
AR063602A1 (es) | Derivados de espiroindolinona, formulaciones farmaceuticas que los contienen y su uso en la obtencion de un medicamento para el tratamiento de trastornos oncologicos. | |
AR060590A1 (es) | Compuestos imidazo | |
AR083200A1 (es) | Compuestos de n-heteroarilo | |
AR059957A1 (es) | DERIVADOS DE ESPIROINDOLINONA, MÉTODOS PARA SU PREPARACIoN, UNA COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE Y SU USO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DEL CÁNCER. | |
AR088029A1 (es) | Compuestos de pirimidina sustituidos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento del dolor, accidentes cerebrovasculares, epilepsia y otras enfermedades del sistema nervioso central | |
AR038000A1 (es) | Compuesto derivado de tien[2,3-d]pirimidin-2,4(1h,3h)-diona, composicion farmaceutica, proceso para su preparacion y su uso en la fabricacion de un medicamento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |